PRTA
Prothena Corp Plc
NASDAQ · Biotechnology
$8.91
+0.56 (+6.71%)
Open$8.58
Previous Close$8.35
Day High$8.99
Day Low$8.56
52W High$16.67
52W Low$4.32
Volume—
Avg Volume442.7K
Market Cap479.63M
P/E Ratio—
EPS$-5.21
SectorBiotechnology
Analyst Ratings
Buy
13 analysts
Price Target
+51.7% upside
Current
$8.91
$8.91
Target
$13.52
$13.52
$9.22
$13.52 avg
$14.31
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 135.30M | 154.33M | 161.59M |
| Net Income | -122,441,672 | -125,695,796 | -23,577,083 |
| Profit Margin | -90.5% | -86.0% | -14.6% |
| EBITDA | -154,018,338 | -166,895,655 | -38,324,386 |
| Free Cash Flow | — | — | -23,372,794 |
| Rev Growth | -12.3% | -12.3% | +2.5% |
| Debt/Equity | — | — | 0.38 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |